In ART settings, CD138+ plasma cells and NK cell abnormalities have shown particular relevance in frozen embryo transfer (FET) cycles under hormone replacement therapy (HRT), where the lack of endogenous immunomodulation by the corpus luteum may increase susceptibility to immune dysfunction. The gene discussed is SDC1; the disease is immune system disorder.